Ups and downs in prescription drug ranking
This first quarter’s ranking of prescription drugs was fluctuated due to patent expirations of original products.
Positions of Baraclude(BMS) and Celebrex(Pfizer) dropped due to their price cuts caused by the last year’s patent expirations. On the other hand, a new hepatitis C treatment, Daklin...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
